These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 19940491
1. Adult outcomes of patients with juvenile idiopathic arthritis. Minden K. Horm Res; 2009 Nov; 72 Suppl 1():20-5. PubMed ID: 19940491 [Abstract] [Full Text] [Related]
2. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chédeville G, Chetaille AL, Saint-Cyr C, Cabral DA, Spiegel LR, Schneider R, Lang B, Huber AM, Dancey P, Silverman E, Rosenberg AM, Cameron B, Johnson N, Dorval J, Scuccimarri R, Campillo S, Petty RE, Duffy KN, Boire G, Haddad E, Houghton K, Laxer R, Turvey SE, Miettunen P, Gross K, Guzman J, Benseler S, Feldman BM, Espinosa V, Yeung RS, Tucker L. Arthritis Care Res (Hoboken); 2010 Apr; 62(4):527-36. PubMed ID: 20391508 [Abstract] [Full Text] [Related]
3. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology. Arthritis Rheum; 2011 Sep; 63(9):2809-18. PubMed ID: 21560116 [Abstract] [Full Text] [Related]
4. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM. Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553 [Abstract] [Full Text] [Related]
5. Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis. Simon D, Bechtold S. Horm Res; 2009 Nov; 72 Suppl 1():55-9. PubMed ID: 19940497 [Abstract] [Full Text] [Related]
6. Update on treatment of arthritis in children: new treatments, new goals. Lovell DJ. Bull NYU Hosp Jt Dis; 2006 Nov; 64(1-2):72-6. PubMed ID: 17121494 [Abstract] [Full Text] [Related]
7. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW. Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443 [Abstract] [Full Text] [Related]
8. [Juvenile idiopathic arthritis]. Herlin T. Ugeskr Laeger; 2002 Aug 19; 164(34):3941-6. PubMed ID: 12212473 [Abstract] [Full Text] [Related]
9. Natural history of growth and body composition in juvenile idiopathic arthritis. Bechtold S, Roth J. Horm Res; 2009 Nov 19; 72 Suppl 1():13-9. PubMed ID: 19940490 [Abstract] [Full Text] [Related]
10. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. Simon D, Fernando C, Czernichow P, Prieur AM. J Rheumatol; 2002 Jun 19; 29(6):1296-300. PubMed ID: 12064849 [Abstract] [Full Text] [Related]
11. Juvenile idiopathic arthritis--current and future therapies. Kahn P. Bull NYU Hosp Jt Dis; 2009 Jun 19; 67(3):291-302. PubMed ID: 19852753 [Abstract] [Full Text] [Related]
12. Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis. Souza L, Machado SH, Bredemeier M, Brenol JC, Xavier RM. J Rheumatol; 2006 Mar 19; 33(3):601-8. PubMed ID: 16511929 [Abstract] [Full Text] [Related]
13. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P. Ann Rheum Dis; 2011 Sep 19; 70(9):1605-12. PubMed ID: 21623000 [Abstract] [Full Text] [Related]
14. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents. Lurati A, Pontikaki I, Teruzzi B, Desiati F, Gerloni V, Gattinara M, Cimaz R, Fantini F. Arthritis Rheum; 2006 May 19; 54(5):1602-7. PubMed ID: 16646003 [Abstract] [Full Text] [Related]
15. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy. Beresford MW, Baildam EM. Arch Dis Child Educ Pract Ed; 2009 Oct 19; 94(5):144-50. PubMed ID: 19770494 [Abstract] [Full Text] [Related]
16. Update on biologicals for treatment of juvenile idiopathic arthritis. Horneff G. Expert Opin Biol Ther; 2013 Mar 19; 13(3):361-76. PubMed ID: 23289865 [Abstract] [Full Text] [Related]
17. Long-term outcome in patients with juvenile idiopathic arthritis. Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, Zink A. Arthritis Rheum; 2002 Sep 19; 46(9):2392-401. PubMed ID: 12355487 [Abstract] [Full Text] [Related]
18. Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis. Vojvodich PF, Hansen JB, Andersson U, Sävendahl L, Hagelberg S. J Rheumatol; 2007 Dec 19; 34(12):2481-5. PubMed ID: 18050366 [Abstract] [Full Text] [Related]
19. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. Bechtold S, Ripperger P, Häfner R, Said E, Schwarz HP. J Pediatr; 2003 Oct 19; 143(4):512-9. PubMed ID: 14571231 [Abstract] [Full Text] [Related]
20. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, Pederzoli S, Davì S, Martini A, Ravelli A, Paediatric Rheumatology International Trials Organization. Arthritis Rheum; 2012 Jul 19; 64(7):2366-74. PubMed ID: 22231288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]